Finally, it was observed that SIRT1 overexpression is associated with decreased miR-200a in breast cancer patient samples, indicating that miR-200a may be a potential tumor suppression target in breast cancer metastasis [42]. This evidence concerns the gene SIRT1 and breast carcinoma.